FDA
The union for managers and professionals in public service
Home  >  Topic Search Results

Topic Search Results

Showing articles tagged with: FDA in the News
 

FDA General Secretary Dave Penman criticises the “obvious contradiction” in the government’s approach to investigating individuals.

04 July 2023
News
IEPBercow555

General Secretary Dave Penman said the report had “upheld the complaints against Mr. Bercow, and also addressed his repeated assertions around conspiracy among the complainants”.

09 March 2022
News
Stormont-shutterstock-thumbnail-555

General Secretary Dave Penman responds to the announcement of the suspension of Irish Sea border checks.

03 February 2022
News

FDA General Secretary Dave Penman said that the Prime Minister was failing to recognise “the innovation and flexibility” shown by the civil service.

26 January 2022
News
Boris-Johnson-2020-555

Findings represent a clear rejection of the idea that there are different standards for ministers than for civil servants.

09 December 2021
News
House of commons in the evening

FDA General Secretary Dave Penman has condemned “completely unacceptable” personal attacks on the Parliamentary Commissioner for Standards – “a public servant who cannot answer back”

04 November 2021
News
CPSLImage555

General Secretary Dave Penman welcomed the “comprehensive report”, which details “where urgent action is needed to restore public faith”

01 November 2021
News
Oliver Dowden555

FDA General Secretary Dave Penman has accused the Conservative Co-Chair of pandering to the party faithful.

07 October 2021
News

FDA General Secretary Dave Penman has responded to concerns raised by Lady Heywood that the Greensill inquiry will “dump the blame" on her late husband.

01 July 2021
News
Boris-Johnson-2020-555

General Secretary Dave Penman has responded to decision of the courts to grant a full hearing.

27 April 2021
News
ScotParl555x335

General Secretary Dave Penman has responded to press reports regarding the costs of support for civil service witnesses to the Salmond inquiry.

18 January 2021
News
Ofsted555x335

The FDA has welcomed the decision by Ofsted to move to remote inspections until after the February half term.

12 January 2021
News

95% voted to support the action and to progress the FDA’s long-running ‘Equal value, equal worth’ campaign for pay parity between COPFS and equivalent roles in the Scottish Government.

23 December 2020
News

The FDA has branded the government’s decision to scrap unconscious bias training for civil servants as “absolutely illogical” and has criticised ministers for making the announcement without producing any proposals for what will replace it.

18 December 2020
News
HighCourt555x335

The FDA has launched a legal challenge against the imposition by the government of a £95,000 cap on public sector exit payments. The union is seeking, via a Judicial Review, to challenge the government’s 2020 regulations restricting exit payments.

08 December 2020
News

The FDA has launched an indicative ballot of members working in the Crown Office and Procurator Fiscal Service on possible industrial action over pay.

03 December 2020
News
Home-Office-exterior-555

FDA calls for “an independent and transparent process where bullying and harassment allegations against ministers can be dealt with effectively, free from political interference.”

24 November 2020
News
DEFRA555x335

The FDA has requested a meeting with the Secretary State at Defra after members rejected the department's pay offer.

12 October 2020
News
Home-Office-exterior-555

FDA General Secretary Dave Penman calls for urgent decision on investigation into bullying allegations against the Home Secretary.

06 October 2020
News
Stormont-shutterstock-thumbnail-555

FDA General Secretary Dave Penman has described it as “extraordinary” and “astonishing” that the First and Deputy First Minister of Northern Ireland have failed to appoint a new head of the Northern Ireland Civil Service.

24 September 2020
News
12
Find us
FDA, Centenary House, 93-95 Borough High Street, London, SE1 1NL                      
Copyright © 2024 FDA